Stryker Corp: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 1, 2024 and accepted by EDGAR at May 1, 2024, 11:52 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $5.24bn | us-gaap:Revenues |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $1.91bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $3.33bn | us-gaap:GrossProfit |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $368.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $1.84bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $972.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $135.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $788.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $2.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $2.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 385,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | $204.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $167.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2024-01-01 to 2024-03-31 | $304.0m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2024-03-31 | $2.33bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $11.89bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $39.40bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $6.96bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $20.23bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $10.81bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $2.06bn | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2024-03-31 | $0 | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2024-03-31 | $19.17bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2024-03-31 | 380,949,778 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000310764-24-000064. Last ingested by Listed: Nov 5, 2026, 19:29 ET. Listed shows no prices and gives no investment advice.